Reviews |
From the Department of Pediatrics (K.R.S., M.G.F.), Developmental Lung Biology Laboratory; and Department of Medicine (K.A.F.), Cardiovascular Pulmonary Research Laboratory, University of Colorado at Denver and Health Sciences Center.
Correspondence to Kurt R. Stenmark, MD, Professor of Pediatrics, Head, Pediatric Critical Care Medicine, Developmental Lung Biology Laboratory, 4200 E 9th Ave, Box B131, Denver, CO 80262. E-mail Kurt.Stenmark{at}UCHSC.edu
Chronic hypoxic exposure induces changes in the structure of pulmonary arteries, as well as in the biochemical and functional phenotypes of each of the vascular cell types, from the hilum of the lung to the most peripheral vessels in the alveolar wall. The magnitude and the specific profile of the changes depend on the species, sex, and the developmental stage at which the exposure to hypoxia occurred. Further, hypoxia-induced changes are site specific, such that the remodeling process in the large vessels differs from that in the smallest vessels. The cellular and molecular mechanisms vary and depend on the cellular composition of vessels at particular sites along the longitudinal axis of the pulmonary vasculature, as well as on local environmental factors. Each of the resident vascular cell types (ie, endothelial, smooth muscle, adventitial fibroblast) undergo site- and time-dependent alterations in proliferation, matrix protein production, expression of growth factors, cytokines, and receptors, and each resident cell type plays a specific role in the overall remodeling response. In addition, hypoxic exposure induces an inflammatory response within the vessel wall, and the recruited circulating progenitor cells contribute significantly to the structural remodeling and persistent vasoconstriction of the pulmonary circulation. The possibility exists that the lung or lung vessels also contain resident progenitor cells that participate in the remodeling process. Thus the hypoxia-induced remodeling of the pulmonary circulation is a highly complex process where numerous interactive events must be taken into account as we search for newer, more effective therapeutic interventions. This review provides perspectives on each of the aforementioned areas.
Key Words: pulmonary hypertension pulmonary vasoconstriction fibrocyte inflammation progenitor cell adventitia
This article has been cited by other articles:
![]() |
L. De Franceschi, O. S. Platt, G. Malpeli, A. Janin, A. Scarpa, C. Leboeuf, Y. Beuzard, E. Payen, and C. Brugnara Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice FASEB J, June 1, 2008; 22(6): 1849 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, D. A. Quinn, H. G. Garg, and C. A. Hales Deficiency of the NHE1 Gene Prevents Hypoxia-induced Pulmonary Hypertension and Vascular Remodeling Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1276 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Das, N. Burns, S. J. Wilson, W. M. Zawada, and K. R. Stenmark Hypoxia exposure induces the emergence of fibroblasts lacking replication repressor signals of PKC{zeta} in the pulmonary artery adventitia Cardiovasc Res, June 1, 2008; 78(3): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kumar, B. G. Branch, C. B. Pattillo, J. Hood, S. Thoma, S. Simpson, S. Illum, N. Arora, J. H. Chidlow Jr., W. Langston, et al. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis PNAS, May 27, 2008; 105(21): 7540 - 7545. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Fredenburgh, O. D. Liang, A. A. Macias, T. R. Polte, X. Liu, D. F. Riascos, S. W. Chung, S. L. Schissel, D. E. Ingber, S. A. Mitsialis, et al. Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells Circulation, April 22, 2008; 117(16): 2114 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. S. Broughton, B. R. Walker, and T. C. Resta Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L797 - L806. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Leuchte, T. Meis, M. El-Nounou, J. Michalek, and J. Behr Inhalation of endothelin receptor blockers in pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L772 - L777. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asosingh, M. A. Aldred, A. Vasanji, J. Drazba, J. Sharp, C. Farver, S. A.A. Comhair, W. Xu, L. Licina, L. Huang, et al. Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension Am. J. Pathol., March 1, 2008; 172(3): 615 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. BelAiba, S. Bonello, C. Zahringer, S. Schmidt, J. Hess, T. Kietzmann, and A. Gorlach Hypoxia Up-Regulates Hypoxia-Inducible Factor-1{alpha} Transcription by Involving Phosphatidylinositol 3-Kinase and Nuclear Factor {kappa}B in Pulmonary Artery Smooth Muscle Cells Mol. Biol. Cell, December 1, 2007; 18(12): 4691 - 4697. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Carlin, A. J. Peacock, and D. J. Welsh Fluvastatin Inhibits Hypoxic Proliferation and p38 MAPK Activity in Pulmonary Artery Fibroblasts Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 447 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, T. Okada, H. Miyashita, T. Nomoto, M. Nonaka-Sarukawa, R. Uchibori, Y. Maeda, M. Urabe, H. Mizukami, A. Kume, et al. Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats Circ. Res., September 28, 2007; 101(7): 734 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Patel, D. J. Lederer, A. C. Borczuk, and S. M. Kawut Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis Chest, September 1, 2007; 132(3): 998 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Sanders and J. R. Hoidal The NOX on Pulmonary Hypertension Circ. Res., August 3, 2007; 101(3): 224 - 226. [Full Text] [PDF] |
||||
![]() |
M. Mittal, M. Roth, P. Konig, S. Hofmann, E. Dony, P. Goyal, A.-C. Selbitz, R. T. Schermuly, H. A. Ghofrani, G. Kwapiszewska, et al. Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature Circ. Res., August 3, 2007; 101(3): 258 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Akhavein, E. J. St.-Michel, E. Seifert, and C. V. Rohlicek Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats J Appl Physiol, July 1, 2007; 103(1): 287 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zakrzewicz, M. Hecker, L. M. Marsh, G. Kwapiszewska, B. Nejman, L. Long, W. Seeger, R. T. Schermuly, N. W. Morrell, R. E. Morty, et al. Receptor for Activated C-Kinase 1, a Novel Interaction Partner of Type II Bone Morphogenetic Protein Receptor, Regulates Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension Circulation, June 12, 2007; 115(23): 2957 - 2968. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Herrera, V. M. Pulgar, R. A. Riquelme, E. M. Sanhueza, R. V. Reyes, G. Ebensperger, J. T. Parer, E. A. Valdez, D. A. Giussani, C. E. Blanco, et al. High-altitude chronic hypoxia during gestation and after birth modifies cardiovascular responses in newborn sheep Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2234 - R2240. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |